The Genesis Protocol - 13 Compound Integrative Cancer Support System

What it does:

Destabilizes microtubules in cancer cells (the same mechanism chemotherapy taxanes use), blocks glucose uptake, and induces apoptosis. Also targets glutamine metabolism, which many tumors depend on when glucose is restricted.

The science:

Benzimidazoles like fenbendazole trigger G2/M cell cycle arrest and anti-angiogenesis. Apoptosis runs through mitochondrial injury and p53 (Mukhopadhyay et al., 2002; Park et al., 2022). Fenbendazole also targets cancer stem cells and chemoresistant cells that standard therapy leaves behind (Son et al., 2020).

Case evidence:

Three patients with stage IV genitourinary cancers at 1,000mg three times weekly reached complete remission (Chiang et al., 2021). Two had been progressing despite multiple prior treatments.

What it does:

Induces autophagy and apoptosis in cancer cells through mitochondrial dysfunction. Regulates pyruvate kinase at the last step of glycolysis. Has a selective pro-oxidant effect on cancer cells while sparing healthy ones.

The science:

Ivermectin triggers apoptosis through mitochondrial dysfunction (Juarez et al., 2018; Tang et al., 2021). In vitro, it inhibits cancer stem cells more effectively than standard chemotherapy drugs like paclitaxel (Dominguez-Gomez et al., 2018). In vivo, ivermectin alone outperformed gemcitabine at reducing tumor weight and volume in pancreatic models (Lee et al., 2022).

Safety profile:

Single doses up to 2mg/kg showed no serious adverse reactions in healthy volunteers (Guzzo et al., 2002). Patients taking up to 1mg/kg daily for 180 consecutive days experienced no serious adverse effects (de Castro et al., 2020).

What it does:

At high doses, Vitamin C acts as a pro-oxidant in cancer cells (not an antioxidant), generating hydrogen peroxide that selectively kills them while protecting healthy cells. Competes directly with glucose for cellular entry via GLUT1 receptors.

The science:

High-dose Vitamin C kills cancer cells through a pro-oxidant mechanism but not normal cells (Chen et al., 2005, 2008). It inhibits both glycolysis (Aguilera et al., 2016) and the pentose phosphate pathway in cancer cells, while sparing healthy cells that have catalase to neutralize H2O2.

Why liposomal:

Achieves plasma concentrations approaching IV administration without clinic visits. Standard oral Vitamin C is poorly absorbed. Liposomal delivery dramatically increases bioavailability.

What it does:

Targets mitochondria by improving metabolism and regulating respiration. Inhibits both glycolysis and glutaminolysis pathways. Targets cancer stem cells and metastasis.

The science:

Meta-analyses show inverse correlations between serum Vitamin D levels and incidence across at least 12 different cancer types (Muñoz & Grant, 2022). Chandler et al. demonstrated a 37% reduction in metastatic incidence and 42% reduction in mortality with supplementation in a published clinical study. VDR activation suppresses Wnt/β-catenin signaling in cancer stem cells.

What it does:

Protects mitochondria from reactive oxygen species damage. Induces mitochondrial pyruvate transport, oxidative phosphorylation, and ATP production. Blocks energy production in cancer cells and inhibits glycolysis.

The science:

There are 151 publications confirming the link between zinc deficiency and cancer (Sugimoto et al., 2024). Zinc deficiency is implicated in esophageal, liver, lung, breast, and colon cancer. Zinc has a selective pro-oxidant effect on cancer cells and has been studied for blocking their energy production. Copper is included to maintain essential mineral balance.

What it does:

Potent anti-inflammatory that synergizes with Fenbendazole. Inhibits the NF-κB pathway (master regulator of inflammation), induces apoptosis, and has demonstrated effects on cancer stem cells.

The science:

Curcumin enhances the effects of conventional treatments while reducing their side effects. Multiple studies show it targets cancer stem cells through Wnt/β-catenin, Notch, and Hedgehog pathways. The inflammation-cancer connection is direct: NF-κB is constitutively active in most cancer cells. Piperine increases curcumin bioavailability by 2,000%.

What it does:

Reduces inflammation, enhances apoptosis in cancer cells, and provides neuroprotective effects. Also helps with pain management, sleep quality, and anxiety, which matter for quality of life during treatment.

The science:

CBD induces apoptosis through multiple mechanisms including ceramide accumulation and ER stress. It enhances the effects of conventional treatments in preclinical models. Beyond direct cellular effects, CBD's support for sleep and stress reduction has measurable immune benefits, because immune surveillance peaks during quality sleep.

What it does:

Binds iron, depriving cancer cells of a key nutrient. Modulates immune function. Synergizes with Ivermectin for enhanced effects.

The science:

Cancer cells require significantly more iron than healthy cells. Lactoferrin's iron-chelating properties selectively starve those cells. It also activates NK cells and macrophages while inhibiting cancer cell proliferation through cell cycle arrest. Research shows synergistic effects with Ivermectin in targeting cancer stem cells.

What it does:

Contains thymoquinone, which induces apoptosis, inhibits proliferation, and supports detoxification pathways. Powerful antioxidant for healthy cell protection.

The science:

Thymoquinone has demonstrated effects against cancer cells through ROS generation, cell cycle arrest, and apoptosis induction. It protects healthy cells from oxidative damage during treatment protocols. Traditional use for over 2,000 years, with modern research validating its mechanisms across multiple published studies.

What it does:

Contains EGCG, which inhibits glutamine pathways and boosts oxidative phosphorylation (OxPhos), the healthy energy production pathway cancer cells can't use effectively.

The science:

EGCG inhibits glutamine uptake and metabolism in cancer cells. It also enhances mitochondrial function in healthy cells, creating a metabolic advantage. Multiple epidemiological studies link green tea consumption to reduced cancer incidence. EGCG synergizes with Fenbendazole and Ivermectin's metabolic targeting.

What it does:

Protects liver function during intensive protocols. Contains silymarin, which has direct effects on cancer cells while supporting detoxification.

The science:

Silymarin protects hepatocytes from toxicity while independently inhibiting cancer cell growth through multiple mechanisms. Essential for high-dose regimens involving Fenbendazole and Ivermectin, which are metabolized by the liver. Also supports glutathione production, the body's master antioxidant.

What it does:

Blocks galectin-3, a protein cancer cells use for adhesion, aggregation, and spread. Supports detoxification of heavy metals.

The science:

Galectin-3 is overexpressed in cancer cells and facilitates metastatic spread. Modified citrus pectin binds galectin-3, inhibiting cell-to-cell adhesion and blocking a key metastatic pathway. Clinical studies show reductions in PSA doubling time and other markers. Also chelates heavy metals without depleting essential minerals.

What it does:

Contains PSK and PSP polysaccharides that enhance immune function, particularly NK cell and T-cell activity. Used for decades in Japan as an adjunct to conventional cancer treatments.

The science:

PSK (Krestin) is an approved adjunct therapy in Japan with extensive clinical research. Meta-analyses show improved survival rates when added to standard treatments. Enhances both innate and adaptive immunity, helping the body recognize and target cancer cells. Over 40 clinical trials published.